-Kevin M Koch Researcher Activity Profile

Research Author Detailed Information 

Kevin M Koch Publication Rate By Year

Kevin M Koch has published 3 paper(s) in 1976, 1 paper(s) in 1978, 3 paper(s) in 1979, 1 paper(s) in 1981, 1 paper(s) in 1982, 3 paper(s) in 1984, 2 paper(s) in 2006, 9 paper(s) in 2007, 1 paper(s) in 2008, for a total of 24 research publications in total.

Kevin M Km Koch Author Information

LAST NAME: koch

FIRST NAME: Kevin M

INITIALS: km

AFFILIATION:

Papers

Kevin M Koch's Publication Record

1. Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancer. Year Published: 2006
Lymphoma Program, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. mjrobert@iupui.edu
2. Rapid calculations of susceptibility-induced magnetostatic field perturbations for in vivo magnetic resonance. Year Published: 2006
Yale University, Magnetic Resonance Research Center, New Haven, CT, USA.
3. Dynamically shimmed multivoxel 1H magnetic resonance spectroscopy and multislice magnetic resonance spectroscopic imaging of the human brain. Year Published: 2007
Yale Magnetic Resonance Research Center, New Haven, Connecticut 06520-8043, USA. kevin.koch@yale.edu
4. Distribution of resistant gram-positive organisms across the census regions of the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial. Year Published: 2007
Clarian Health Partners, Inc., Indianapolis, Indiana 46202, USA. gdenys@clarian.org
5. The value of label recommendations: how to dose lapatinib. Year Published: 2007
6. The value of label recommendations: how to dose lapatinib. Year Published: 2007
7. A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecan. Year Published: 2007
Department of Clinical Pharmacology, University of Oxford, Oxford, UK.
8. A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecan. Year Published: 2007
Department of Clinical Pharmacology, University of Oxford, Oxford, UK. Rachel.Midgley@cancer.org.uk
9. Dynamically shimmed multivoxel 1H magnetic resonance spectroscopy and multislice magnetic resonance spectroscopic imaging of the human brain. Year Published: 2007
Yale Magnetic Resonance Research Center, New Haven, Connecticut 06520-8043, USA. kevin.koch@yale.edu
10. A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecan. Year Published: 2007
Department of Clinical Pharmacology, University of Oxford, Oxford, UK. Rachel.Midgley@cancer.org.uk
11. A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecan. Year Published: 2007
Department of Clinical Pharmacology, University of Oxford, Oxford, UK. Rachel.Midgley@cancer.org.uk
12. [Behavior of Newcastle disease virus in the airborne state. 1. Experimental study of particle binding of the virus] Year Published: 1984
13. [Behavior of Newcastle disease virus in the airborne state. 2. Estimation of aerogenic dissemination] Year Published: 1984
14. Plasma noradrenaline levels in regular haemodialysis patients. Year Published: 1976
15. Occult blood loss and iron balance in chronic renal failure. Year Published: 1976
16. Factors predisposing to priapism in haemodialysis patients. Year Published: 1976
17. The variable role of erythropoietin deficiency in the pathogenesis of dialysis anaemia. Year Published: 1978
18. Comparison of haemodialysis (HD) and post dilution haemofiltration (HF) on an unselected dialysis population. Year Published: 1979
19. Sustained negative feedback between haematocrit and serum erythropoietin concentration in end-stage renal failure. Year Published: 1979
20. Total parathyroidectomy with autograft of parathyroid tissue in treatment of secondary hyperparathyroidism. Year Published: 1979
21. Differing haemodynamic stability due to differing sympathetic response: comparison of ultrafiltration, haemodialysis and haemofiltration. Year Published: 1981
22. Tumour-like growth of parathyroid autografts in uraemic patients. Year Published: 1982
23. Effect of secondary hyperparathyroidism on the anaemia of end-stage renal failure: in vivo and in vitro studies. Year Published: 1984
24. The role of efflux and uptake transporters in N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, lapatinib) disposition and drug interactions. Year Published: 2008
Preclinical Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Inc., P.O. Box 13398, Room MAI.A2213, Research Triangle Park, NC 27709, USA. joseph.w.polli@gsk.com